Related Experiment Video
Updated: Jul 15, 2026
09:18
Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Understanding interactions between and among apoptosis inducing pathways in tumor cells
1Department of Biochemistry and Molecular Biology, Brody School of Medicine, East Carolina University, Greenville, NC 27834, USA.
In Vivo (Athens, Greece)
|April 18, 2007
Summary
Fenretinide enhances tumor cell apoptosis by interacting with NF-kappa B inhibition pathways. This finding could improve cancer treatment protocols using fenretinide, parthenolide, and BAY 11-7085.
Area of Science:
- * Molecular Biology
- * Cancer Research
- * Pharmacology
Background:
- * Apoptosis, or programmed cell death, is crucial in cancer therapy and can be induced via three distinct pathways: cell surface receptors, mitochondria, and endoplasmic reticulum.
- * The synergistic or antagonistic interactions between these apoptotic pathways remain incompletely understood.
- * Nuclear factor-kappa B (NF-kappa B) activation is a key survival pathway in many tumors, and its inhibition is a target for cancer drugs.
Purpose of the Study:
- * To investigate the interaction between fenretinide and inhibitors of NF-kappa B activation (parthenolide and BAY 11-7085) in inducing tumor cell apoptosis.
- * To determine if fenretinide potentiates the apoptotic effects of NF-kappa B inhibitors.
- * To explore the role of p53 status in mediating fenretinide's effects on apoptosis.
Main Methods:
- * Treatment of L1210 cell lines (p53-deficient and p53-mutant) with fenretinide, parthenolide, and BAY 11-7085, individually and in combination.
- * Assessment of apoptosis induction and potentiation at specific drug concentrations.
- * Comparative analysis of drug effects based on p53 expression in cell lines.
Main Results:
- * Fenretinide significantly potentiated the apoptotic effects of parthenolide and BAY 11-7085 in p53-deficient L1210 cells.
- * This potentiation occurred at fenretinide concentrations that had minimal effect alone.
- * Fenretinide did not enhance apoptosis in p53-mutant L1210 cells, suggesting a p53-dependent or related mechanism.
- * The findings indicate fenretinide modulates a pathway interacting with NF-kappa B inhibition for apoptosis induction.
Conclusions:
- * Fenretinide interacts with the NF-kappa B pathway to enhance tumor cell apoptosis, particularly in a p53-deficient context.
- * Understanding these pathway interactions can inform the development of combination therapies.
- * This research may lead to optimized clinical protocols utilizing fenretinide, parthenolide, and BAY 11-7085 for enhanced cancer treatment.
Related Concept Videos
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:30Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
01:22Cellular Injury V: Apoptosis and Autophagy
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
01:30Overview of Cell Death
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...